Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil + Ketamine vs Midazolam + Fentanyl for Bronchoscopy
NCT03613792Phase 4Withdrawn
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Sep 2023
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of remifentanil, ketamine in excessive dynamic airway collapse (EDAC), sponsored by Beth Israel Deaconess Medical Center. Planned start Sep 2023; status: withdrawn.
02
Drugs
remifentanilketamine
03
Conditions
excessive dynamic airway collapse (EDAC)
Beyond the preview
Go deeper on NCT03613792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03613792.